Provided by Tiger Fintech (Singapore) Pte. Ltd.

Lantheus

55.66
-0.5000-0.89%
Volume:918.29K
Turnover:51.29M
Market Cap:3.78B
PE:14.75
High:56.88
Open:56.41
Low:55.47
Close:56.16
52wk High:118.21
52wk Low:47.25
Shares:67.99M
Float Shares:59.94M
Volume Ratio:0.34
T/O Rate:1.53%
Dividend:- -
Dividend Rate:- -
EPS(TTM):3.77
EPS(LYR):4.52
ROE:24.71%
ROA:13.34%
PB:3.24
PE(LYR):12.33

Loading ...

Lantheus Holdings Inc - New Formulation Expected to Offer Efficacy Consistent With Pylarify

THOMSON REUTERS
·
Aug 06

Lantheus Holdings Inc - FDA Sets Action Date Goal of March 6, 2026 for Nda

THOMSON REUTERS
·
Aug 06

Lantheus Announces FDA Acceptance of NDA for New Formulation for Market-Leading PSMA PET Imaging Agent

GlobeNewswire
·
Aug 06

Does Lantheus Holdings (NASDAQ:LNTH) Have A Healthy Balance Sheet?

Simply Wall St.
·
Aug 03

Lantheus Holdings Inc : Leerink Partners Cuts Target Price to $134 From $137

THOMSON REUTERS
·
Jul 29

Lantheus to Host Second Quarter 2025 Earnings Conference Call and Webcast on August 6, 2025, at 8:00 a.m. Eastern Time

GlobeNewswire
·
Jul 23

Lantheus Completes Acquisition of Life Molecular Imaging

TIPRANKS
·
Jul 22

Lantheus Holdings Inc. Appoints Dr. Ludger Dinkelborg as Head of R&D Following Acquisition of Life Molecular Imaging

Reuters
·
Jul 22

Lantheus falls -8.7%

TIPRANKS
·
Jul 16

Optimistic Growth Prospects for Lantheus Amid Pricing Challenges: A Buy Recommendation

TIPRANKS
·
Jul 16

Lantheus investors likely disappointed with CMS proposal, says William Blair

TIPRANKS
·
Jul 16

William Blair Sticks to Its Hold Rating for Lantheus (LNTH)

TIPRANKS
·
Jul 16

Life Healthcare Group Holdings Limited Announces Fulfilment of Conditions for Life Molecular Imaging Disposal to Conclude on 21 July 2025

Reuters
·
Jul 14

Returns on Capital Paint A Bright Future For Lantheus Holdings (NASDAQ:LNTH)

Simply Wall St.
·
Jul 12

Lantheus Holdings Inc. Officer Daniel Niedzwiecki Reports Disposal of Common Shares

Reuters
·
Jun 18

CFO and Treasurer Robert J. Marshall Jr. Reports Disposal of Lantheus Holdings Inc. Common Shares

Reuters
·
Jun 12

Lantheus Holdings Inc. Unveils New Clinical Study on Novel FAP-Targeting Radiopharmaceutical at 2025 SNMMI Annual Meeting

Reuters
·
Jun 12

Paul Blanchfield, President of Lantheus Holdings Inc., Reports Disposal of Common Shares

Reuters
·
Jun 10

Lantheus Holdings Inc. Officer Daniel Niedzwiecki Reports Disposal of Common Shares

Reuters
·
Jun 10

Director Mary Anne Heino Reports Disposal of Common Shares of Lantheus Holdings Inc

Reuters
·
Jun 05